Thermo Fisher Scientific Inc. (NYSE:TMO)

The cash flow statement reveals a complex pattern of activity over the five-year period. While operating activities consistently generate positive cash flow, significant fluctuations occur in investing and financing activities, resulting in varying net changes in cash position.

Operating Activities

Net cash provided by operating activities demonstrates relative stability, beginning at US$9,312 million in 2021 and decreasing to US$7,818 million in 2025. This decrease, though moderate, is notable. Adjustments to reconcile net income to net cash from operations show a general increase from US$1,584 million in 2021 to US$2,451 million in 2023, before declining to US$1,097 million in 2025. Non-cash expenses, including depreciation, amortization, and stock-based compensation, contribute significantly to this adjustment, with a combined increase from US$3,618 million in 2021 to US$3,964 million in 2023, followed by a decrease to US$3,482 million in 2025. Changes in working capital accounts exhibit considerable variability, particularly in accounts receivable, inventories, and contract assets/liabilities, impacting overall operating cash flow.

Investing Activities

Investing activities consistently represent a substantial cash outflow. The largest outflow occurred in 2021 at US$21,932 million, largely driven by significant acquisitions. While acquisition-related outflows decreased in subsequent years, they remained substantial, reaching US$4,037 million in 2025. Purchase of property, plant, and equipment also contributes to the outflow, remaining relatively consistent between US$1,400 million and US$2,523 million annually. Proceeds from the sale of property, plant, and equipment, and cross-currency interest rate swap settlements provide some offset, but are considerably smaller in magnitude. Purchases of investments increased significantly in 2024 and 2025, further contributing to the cash outflow.

Financing Activities

Financing activities demonstrate significant year-to-year fluctuations. 2021 saw a substantial net cash inflow of US$6,581 million, primarily from the issuance of debt. However, 2022 and 2023 experienced net cash outflows, driven by debt repayment and purchases of company common stock. 2024 shows a large net cash outflow of US$6,792 million, largely due to debt repayment and stock repurchases. 2025 reverses this trend with a net cash inflow of US$1,801 million, driven by new debt issuance and commercial paper proceeds. Dividend payments remain relatively stable, ranging from US$455 million to US$636 million annually.

Cash Position

The overall effect of these activities results in a decrease in cash in 2021 and 2024, and a substantial increase in 2025. The cash balance at the end of 2025 reached US$9,879 million, a significant recovery from the low of US$4,040 million at the end of 2024. The exchange rate effect on cash fluctuates, but generally remains within a range of US$-139 million to US$267 million.

In summary, the company maintains positive cash flow from operations, but its overall cash position is heavily influenced by strategic decisions related to acquisitions, debt management, and share repurchases. The significant swings in financing and investing activities require close monitoring to assess the long-term financial health and flexibility of the organization.